PRESS RELEASE published on 07/24/2025 at 18:00, 4 months 12 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 7 bonds in Oxurion, leading to EUR 175,000 capital increase. Oxurion focuses on therapeutic innovation to preserve elderly vision Capital Increase Atlas Special Opportunities Oxurion Therapeutic Innovation Vision Preservation
PRESS RELEASE published on 07/24/2025 at 18:00, 4 months 12 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converteert 7 obligaties in Oxurion, resulterend in EUR 175.000 kapitaalverhoging. Oxurion richt zich op innovatieve geneesmiddelen voor ouderen Kapitaalverhoging Oxurion Atlas Special Opportunities, LLC Innovatieve Geneesmiddelen Ouderen
BRIEF published on 07/23/2025 at 18:05, 4 months 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
BRIEF published on 07/23/2025 at 18:05, 4 months 13 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
PRESS RELEASE published on 07/23/2025 at 18:00, 4 months 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding share threshold crossing under Belgian legislation Transparency Notification Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC Share Threshold
PRESS RELEASE published on 07/23/2025 at 18:00, 4 months 13 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop aandelen. Leuven biofarmaceutisch bedrijf België Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
BRIEF published on 07/22/2025 at 18:05, 4 months 14 days ago Oxurion NV reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Notification De Transparence Oxurion NV Opportunités Spéciales Atlas Législation Belge
BRIEF published on 07/22/2025 at 18:05, 4 months 14 days ago Oxurion NV Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Atlas Special Opportunities Oxurion NV Belgian Legislation
PRESS RELEASE published on 07/22/2025 at 18:00, 4 months 14 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding voting securities selling, crossing under 20% threshold Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Voting Securities
PRESS RELEASE published on 07/22/2025 at 18:00, 4 months 14 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC. Onder 20% drempel door verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
Published on 12/05/2025 at 20:25, 37 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 47 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 12 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 42 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 17 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 2 hours 4 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 47 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 16 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 44 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 44 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 52 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 52 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 4 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
